Long-term outcome in patients with juvenile dermatomyositis: A case series

G Chevalier1, O Fakih2, A Lhose3

  • 1Service de Dermatologie, Inserm 1098 RIGHT, Université de Franche Comté, Centre Hospitalier Universitaire, 3, boulevard Fleming, 25030 Besançon, France.

Insights

Juvenile dermatomyositis (JDM) patients show good long-term functional outcomes, with minimal skin and muscle damage after extended follow-up. Most patients maintain normal muscle strength and experience mild disability, indicating a positive prognosis for JDM.

Area of Science:

  • Rheumatology
  • Pediatric Autoimmunity
  • Dermatology

Background:

  • Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children, with known long-term impacts on multiple organs.
  • Limited data exists on the long-term prognosis and outcomes for JDM patients.

Purpose of the Study:

  • To assess the long-term outcomes in a cohort of juvenile dermatomyositis patients.
  • To evaluate the persistent effects of JDM on skin, muscles, and overall patient well-being.

Main Methods:

  • A cohort of JDM patients underwent detailed assessments by dermatologists and rheumatologists.
  • Validated tools including aCAT, MMT8, CMAS, MDI, CHAQ, and HAQ were used to evaluate disease activity, muscle strength, damage, and disability.
  • Long-term outcomes such as growth, puberty, education, vocation, and comorbidities were recorded.

Main Results:

  • After a mean follow-up of 14.9 years, most patients (71%) showed minimal active skin disease (aCAT score) and significant skin damage (MDI).
  • The majority of patients (71.4%) exhibited normal muscle strength (MMT8 >72), with no severe muscle weakness reported.
  • Disability was mild (CHAQ/HAQ index) in 29% of patients, and quality of life scores were generally favorable.

Conclusions:

  • Long-term follow-up using validated cutaneous and musculoskeletal scores indicates favorable functional outcomes for juvenile dermatomyositis patients.
  • The study suggests that while some long-term damage may persist, JDM patients generally achieve good functional recovery and quality of life.
Abstract

Related Concept Videos

Papillary Dermis01:11

Papillary Dermis

Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...